Info
Management: Stages I–II
ISRT alone results in 10-y RFS of ~40% w/ Stage I pts faring better than Stage II (JCO 1996;14:1282). The current recommended dose is 2400 cGy Observation in selected cases where ISRT may result in significant morbidity w/ systemic being employed when indicated by NCCN/GELF criteria, as for Stages III–IV